Silveira WA, Gonçalves DA, Graça FA, Andrade-Lopes AL, Bergantin LB, Zanon NM, Godinho RO, Kettelhut IC, Navegantes LC. Activating cAMP/PKA signaling in skeletal muscle suppresses the ubiquitin-proteasome-dependent proteolysis: implications for sympathetic regulation. J Appl Physiol 117: [11] [12] [13] [14] [15] [16] [17] [18] [19] 2014 E1483-E1494, 2013), the role of the muscle sympathetic innervation and, more specifically, norepinephrine (NE) in regulating the ubiquitin (Ub)-proteasome system (UPS) remains unknown. Based on previous findings that chemical sympathectomy acutely reduces UPS activity, we hypothesized that muscle NE depletion induces adrenergic supersensitivity in rat skeletal muscles. We report that surgical sympathetic denervation (SDEN), a condition in which only muscle NE from both hindlimbs is depleted, transiently reduced the overall proteolysis and the UPS activity (ϳ25%) in both soleus and extensor digitorum longus muscles. This antiproteolytic response was accompanied by increased activity of adenylyl cyclase (112%), levels of cyclic adenosine monophosphate (cAMP; 191%), and the serine phosphorylation of cAMP response element-binding protein (32%). In extensor digitorum longus from normal rats, NE (10 Ϫ4 M) in vitro increased the levels of cAMP (115%) and the serine phosphorylation of both cAMP response element-binding protein (2.7-fold) and forkhead box class O1 transcription factor. Similar effects were observed in C2C12 cells incubated with forskolin (10 M). In parallel, NE significantly reduced the basal UPS (21%) activity and the mRNA levels of atrophy-related Ub-ligases. Similar responses were observed in isolated muscles exposed to 6-BNZ-cAMP (500 M), a specific PKA activator. The phosphorylation levels of Akt were not altered by SDEN, NE, forskolin or 6-BNZ-cAMP. Our results demonstrate that SDEN induces muscle adrenergic supersensitivity for cAMP leading to the suppression of UPS, and that the suppressive effects of NE on UPS activity and expression of Ubligases can be mediated by the activation of cAMP/PKA signaling, with the inhibition of forkhead box class O1 transcription factor. catecholamines; sympathectomy; proteolysis; atrogin-1; MuRF1 NOREPINEPHRINE (NE) IS A NEUROTRANSMITTER produced by sympathetic nervous system (SNS), and it is released from sympathetic fibers that are distributed widely to the whole body.
Although it is well known that skeletal muscles receive a cholinergic motor innervation, evidence indicates that noradrenergic nerve terminals make close contact with striated muscle fibers in mammals (5, 6) . However, the physiological role of this autonomic innervation in regulating protein metabolism remains unclear.
Most of the metabolic actions of catecholamines in peripheral tissues are exerted through a ␤-adrenoceptor-mediated increase in intracellular cyclic adenosine monophosphate (cAMP) and subsequent activation of cAMP-dependent protein kinase (PKA) and cAMP response element-binding protein (CREB). The intracellular concentration of cAMP in cells is determined via the balance between cAMP production by adenylyl cyclase (AC), and cAMP degradation by phosphodiesterases (PDEs). Catecholamines have been traditionally viewed as catabolic, based on their lipolytic and glycogenolytic functions (27) . However, numerous pharmacological studies, reviewed in Refs. 25 and 33, have shown that ␤ 2 -adrenergic agonists induce hypertrophy of skeletal muscle and blunt muscle atrophy in different conditions, including motor denervation, tumors, sepsis, and sarcopenia (13, 26, 40 ). The precise mechanism through which ␤ 2 -adrenergic agonists produce these effects is not completely known, but they seem to be due, at least in part, to a reduction in the rate of muscle protein breakdown (8, 16, 39) . In fact, the in vitro addition of epinephrine (EPI) or NE induces a reduction in the rate of overall proteolysis (37) , similar to that observed in human beings in vivo (17, 42) . More recently, our laboratory (21) and others (47) have demonstrated that the short-term (3 days) or long-term (10 or 14 days) clenbuterol treatment, a selective ␤ 2 -adrenergic agonist, might attenuate muscle atrophy through inhibitory effects on the ubiquitin (Ub)-proteasome system (UPS), the main intracellular pathway for protein degradation in skeletal muscle (21, 26, 47) . The Ub-conjugation to a protein substrate initiates its degradation by the 26S proteasome complex. In a variety of atrophy conditions, the processes of ubiquitination and degradation are regulated by two muscle-specific Ub-protein ligases (E 3 ): atrogin-1/muscle atrophy F-box and MuRF1 (muscle RING finger 1) (10, 19) . These genes, coined "atrogenes," are regulated by Akt, a critical insulin signaling molecule that regulates muscle mass. One mechanism by which Akt reduces the expression of atrogenes involves the phosphorylation and subsequent nuclear exclusion of the forkhead box transcription factor Foxo (41, 44) . Recent evidence indicates that atrogenes may also be regulated by molecules that act through the cAMP signaling pathway (9, 22) . Indeed, the acute and chronic administration of clenbuterol to rodents suppressed the gene expression of atrogin-1 and MuRF-1 in fast-twitch muscles upon motor denervation (26) and fasting (20) . These effects are probably mediated by cAMP, as drugs that induce an increase in the intracellular concentrations of cAMP, such as the selective and nonselective cAMP-PDE inhibitors, have also been employed in preventing muscle atrophy in rodents (22) . Indeed, nonselective PDE inhibitors or rolipram, a selective PDE-4 inhibitor, reduce the UPS activity and the atrogin-1 mRNA in isolated skeletal muscles from normal rats (30) and in cultured muscle cells incubated with dexamethasone (20) . Although this evidence indicates that the cAMP signaling in skeletal muscles is the mechanism by which catecholamines suppress the Ub-ligases and the UPS, the physiological role of muscle sympathetic innervation, and more specifically, NE, in the control of this proteolytic process, has not been hitherto investigated.
Previous work from our laboratory has shown that the chemical sympathectomy with guanethidine for 2 days increased the Ca 2ϩ -dependent proteolysis in soleus, suggesting that the SNS through catecholamines exerts an inhibitory adrenergic tonus that restrains Ca 2ϩ -dependent protein degradation in oxidative muscles of normal rats (36) . On the other hand, it was also observed that the UPS activity in the extensor digitorum longus (EDL) muscle was reduced after 2 days of guanethidine treatment (36) . This was interpreted as an antiproteolytic response to the adrenergic supersensitivity of the EDL muscles following guanethidine treatment. Because in that study both plasma and muscle catecholamine levels were reduced by chemical sympathectomy, we could not dissociate if the observed effects were due to plasma catecholamines or NE released directly by noradrenergic innervation (36) . To investigate the specific role of NE in the control of skeletal muscle protein synthesis in rodents, we have been using a model of surgical sympathetic denervation (SDEN), a condition in which only muscle NE from both hindlimbs is depleted (35) . However, the consequences of SDEN on muscle protein breakdown have not been examined. In the present studies, we tested the hypothesis that SDEN induces skeletal muscle adrenergic supersensitivity and propose that NE may directly suppress the UPS through a cAMP/PKA-dependent pathway. Specifically, we have examined the in vivo effect of SDEN and in vitro effect of NE and 6-BNZ-cAMP, a specific PKA activator, on overall proteolysis, UPS activity and expression of genes and proteins involved in muscle atrophy, and Akt/ Foxo signaling in isolated rat skeletal muscles. The muscle cAMP levels, AC activity, the phosphorylation of CREB, as well as Akt and Foxo 1, are also reported.
METHODS

Animals.
Because the incubation procedure requires intact muscle sufficiently thin to allow an adequate diffusion of metabolites and oxygen (4), juvenile rats were used in all experiments. Male Wistar rats (80 -100 g) were housed in a room with a 12:12-h light-dark cycle and were given free access to water and normal lab chow diet. Animals were submitted to lumbar sympathetic denervation (SDEN) to deplete the muscle NE content and killed by cervical dislocation 2, 3, 4, and 7 days after surgery. The duration of denervation/sympathectomy was chosen because preliminary experiments showed that 36 h of sympathectomy were sufficient to significantly reduce the skeletal muscles of NE (data not shown). For overall proteolysis assay, we have used six or seven rats from each group and isolated soleus or EDL muscles from one leg. After 2 h of incubation in the presence or not of different compounds, muscles were removed and stored at Ϫ80°C for RT-PCR experiments. Contralateral muscles were removed and stored at Ϫ80°C for AC activity and [
35 S]guanosine 5=-O-(3-thiotriphosphate) (GTP␥S)-binding assays. An additional group composed of seven animals per group was used for muscle NE and cAMP measurements. For the determination of proteolytic systems activities, we have used both muscles (left and right) from the same animal. All rats were killed by cervical dislocation. The protocol studies were approved by Ethical Commission of Ethics in Animal Research from School of Medicine of Ribeirão Preto (017/2009) and agree with Ethical Principles in Animal Research adopted by Brazilian College of Animal Experimentation.
SDEN. The sympathetic denervation surgery was performed with the help of a dissection microscope. For this, the animals were anesthetized with ketamine and xylazine (85 and 10 mg/kg body wt ip, respectively) and kept warm at 37°C on the heating bed during the surgery and allowed to recover from anesthesia (ϳ30 min) before being returned to their normal environment.
The SDEN consisted of the surgical excision of the bilateral second and third lumbar ganglia of the paravertebral sympathetic chain, from which arises the sympathetic fibers to the skeletal muscles of the rat hindlimb (6) . The lumbar sympathetic chain on both sides lies embedded in connective tissue in front of the vertebral column, behind the aorta and vena cava. Sham-operated animals were used as controls (CON). Food consumption was not altered after 2, 3, 4, and 7 days of surgery.
NE measurements. For the determination of muscle NE content, a group of rats was killed 2, 3, 4, and 7 days after SDEN or sham operation, and the EDL and soleus muscles from both hindlimbs (left and right) were harvested and immediately frozen in liquid nitrogen and then stored at Ϫ80°C until assayed. NE was assayed as previously described (18) using HPLC (LC-7A, Shimadzu Instruments) with a Spherisorb ODS-2 (5 m; Sigma-Aldrich) reversed-phase column.
Incubation procedure. The EDL and soleus were rapidly dissected, with care being taken to avoid damaging the muscles. Soleus were maintained at approximately resting length by pinching their tendons in aluminum wire supports, and EDL were maintained by pinning them on inert plastic supports. Tissues were incubated at 37°C in Krebs-Ringer bicarbonate buffer, pH 7.4, equilibrated with 95% O 2/5% CO2, containing glucose (5 mM).
Rates of protein degradation. For measurement of the rate of overall proteolysis and proteolytic activities, skeletal muscles (EDL and soleus) from CON and SDEN rats for 2, 3, 4, and 7 days were incubated as described above. Briefly, after a 2-h incubation period, the overall proteolysis and lysosomal and UPS activities were determined by measuring the rate of tyrosine release in the incubation medium in the presence of cycloheximide (0.5 mM). Since muscle cannot synthesize or degrade tyrosine, its release reflects the rate of protein breakdown. Preliminary experiments showed that, as previously reported for normal animals (4), the intracellular pools of tyrosine of the denervated rats were not significantly affected by all of the incubation conditions used here. Therefore, rates of amino acid release into the medium reflect rates of protein degradation.
For measurement of UPS activity, muscles from one limb were incubated under conditions that prevent activation of the lysosomal (10 mM methylamine and 1 U/ml insulin), branched-chain aminoacid-dependent (170 M leucine, 100 M isoleucine, and 200 M valine), and Ca 2ϩ -dependent (Ca 2ϩ -free medium with cysteine-protease inhibitors, including 25 M E64 and 50 M leupeptin) proteolytic systems. Muscles from the contralateral limb were incubated in the presence of both lysosomal and Ca 2ϩ -dependent proteolytic systems inhibitors, plus the proteasome inhibitor MG132 (20 M) .
For measurement of lysosomal activity, muscles from one limb were incubated in the absence of methylamine, insulin, and branchedchain amino acids, a condition in which the lysosomal system is activated. Contralateral muscles were incubated in the presence of insulin (1 U/ml), leucine (170 M), isoleucine (100 M), valine (200 M), and methylamine (10 mM), a weak base that increases intralysosomal pH and inhibits lysosomal proteolysis. UPS and lysosomal activities were calculated from the difference in tyrosine release between the left and right muscles. Tyrosine release was assayed using the fluorometric method (46) .
Determination of muscle cAMP levels. The intracellular levels of cAMP were measured in EDL and soleus muscles from CON and 3-and 7-day SDEN rats by using a method based on a competitive enzyme immunoassay system (GE Healthcare). Briefly, muscles were homogenized in 6% trichloroacetic acid, and, after extraction of lipid content with diethyl ether, the aqueous phase was lyophilized and resuspended in the assay buffer.
AC activity assay. The AC activity was determined by measuring the formation of cAMP in membrane fractions in EDL and soleus muscles from CON and 3-and 7-day SDEN rats. Muscles were homogenized in 10 volumes (weight/volume) 12.5 mM Tris, pH 7.4 (containing 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1 mM pepstatin A), and the samples were centrifuged at 20,000 g for 10 min at 4°C. The pellet was suspended in the same buffer and centrifuged two times at 20,000 g for 10 min at 4°C. The final pellet was suspended in five volumes of the same buffer, and the protein concentration was determined according to the method described by Bradford (11) using bovine serum albumin (BSA) as standard. For the AC activity assay, the membrane pellet containing 10 g of protein were incubated at 30°C with 12.5 mM Tris, pH 7.4 (containing 0.6 mM ATP, 1 M GTP, 10 mM MgCl 2, 1 mM IBMX, and 1 mg/ml BSA) in the presence of 10 M forskolin (FSK) for 30 min. The reaction was stopped by boiling the samples for 10 min, and the samples were centrifuged for 15 min at 20,000 g. Cyclic AMP from the supernatant was determined using the cAMP kit [ 3 H]-assay system (GE Healthcare, LifeSciences, Fairfield, CT) and expressed as picomoles of cAMP formed per hour per milligram of protein.
[ 35 
S]GTP␥S-binding assay for G protein activation.
The basal and activated G protein levels in EDL muscles from CON and 3-day SDEN rats were determined using the procedure described previously (2) . Briefly, muscles were homogenized in 100 mg/ml (weight/ volume) 50 mM Tris·HCl buffer (pH 7.4) containing 3 mM MgCl2, 100 mM NaCl (reaction buffer), and 1 mM EGTA plus 0.32 M sucrose. The samples were centrifuged two times at 1,000 g for 15 min at 4°C; the supernatant was mixed and centrifuged at 20,000 g for 30 min at 4°C. The final pellet was resuspended in five volumes of the same buffer, and the protein concentration was determined according to the method described by Bradford (11) .
For the functional binding of To remove the free radioligand, the pellets were rinsed with 1.0 ml reaction buffer and centrifuged for 20 min at 15,000 g at 4°C twice. The final pellet was suspended in 200 l of 1% SDS, and the radioactivity was determined by scintillation counting (Micro Beta Jet 1450, Perkin Elmer).
Quantitative PCR. Skeletal muscles were harvested and immediately frozen in liquid nitrogen. RNA was subsequently isolated from individual skeletal muscles using TRIzol (Invitrogen, Carlsbad, CA). Reverse transcription into cDNA was performed using 2 g of total cellular RNA, 20 pmol oligo(dT) primer (Invitrogen), and Advantage ImProm-II reverse transcriptase (Promega, Madison, WI). Real-time PCR was carried out using an ABI7000 sequence detection system (Applied Biosystems, Foster City, CA), a SuperScript III Platinum SYBR Green One-Step RT-qPCR Kit with ROX (Invitrogen), and primers for rat atrogin-1 (forward 5=-GCA GAG AGT CGG CAA GTC-3= and reverse 5=-CAG GTC GGT GAT CGT GAG-3=), MuRF1 (forward 5=-TCG ACA TCT ACA AGC AGG AA-3= and reverse 5=-CTG TCC TTG GAA GAT GCT TT-3=), and cyclophilin B (forward 5=-GCA TAC AGG TCC TGG CAT CT-3= and reverse 5=-CTT CCC AAA GAC CAC ATG CT-3=). The relative quantitation of mRNA levels was plotted as the fold increase compared with the respective CON group values. Transcripts of interest were normalized to cyclophilin B levels. The level of the target transcripts was calculated using the standard curve method (14) .
Western blotting analysis. CREB, Akt, and Foxo1 phosphorylation levels were measured in EDL muscles from CON and 3-and 7-day SDEN rats. Skeletal muscles were homogenized in 50 mM Tris·HCl buffer (pH 7.4) containing 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 1% SDS, 10 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM sodium orthovanadate, 5 g/ml of aprotinin, 1 mg/ml of leupeptin, and 1 mM phenylmethylsulfonyl fluoride at 4°C. The homogenate was centrifuged at 21,000 g at 4°C for 20 min, retaining the supernatant, and protein content was determined using BSA as a standard (32) . An equal volume of sample buffer (20% glycerol, 125 mM Tris·HCl, 4% SDS, 100 mM dithiothreitol, 0.02% bromophenol blue, pH 6.8) was added to the supernatant, and the mixture was boiled. Thirty to one hundred micrograms of total proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes, and blotted with anti-Akt (1:750) NE and 6-BNZ-cAMP in isolated skeletal muscles. To investigate the in vitro effect of NE (10 Ϫ4 M) and 6-BNZ-cAMP (500 M), the cAMP analog that activates PKA, on the UPS activity, cAMP levels, Ub-ligases mRNA expression (atrogin-1 and MuRF1), and protein levels (CREB, Akt, and Foxo1), EDL muscles from normal rats were incubated at different times in the presence, or absence, of each compound using the same procedure described above. Contralateral muscles were incubated with vehicle and used as CON.
Abs, drugs, and reagents. Rabbit polyclonal anti-p-Ser 473 -Akt, anti-Akt, anti-p-Ser 256 -Foxo1, anti-Foxo1 and anti-p-Ser 133 -CREB were purchased from Cell Signaling Technology (Danvers, MA). Mouse anti-␤-actin Ab was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). All drugs and reagents were purchased from Sigma-Aldrich (St. Louis, MO), Thermo Scientific HyClone (Pittsburgh, PA), Invitrogen (Carlsbad, CA), Calbiochem EMD Biosciences (La Jolla, CA), or Amersham Biosciences (Piscataway, NJ).
Statistical analysis. The data are presented as means Ϯ SE. The means from different groups were analyzed using paired or unpaired Student's t-tests. Multiple comparisons were made using one-way ANOVA followed by a Student-Newman-Keuls post hoc test. P Յ 0.05 was taken as the criterion for significance.
RESULTS
Effect of sympathetic denervation on muscle NE. SDEN from 2 to 7 days induced a significant reduction (ϳ85%) in NE content of both EDL and soleus muscles (Fig. 1, A and B,  respectively) . As previously shown (35) , plasma levels of catecholamines were not altered in this experimental model of sympathectomy (Fig. 1, C and D) . The surgery did not affect body weight gain or skeletal muscle weight at any of the experimental periods (data not shown). Averaged values for EDL from CON and SDEN were, respectively (in mg/100 g): at day 3 (40. Effect of sympathetic denervation on rates of protein degradation. As shown in Fig. 2A , SDEN induced a 10-18% decrease in overall proteolysis at 2, 3, and 4 days, but not at 7 days, in both EDL and soleus muscles. In parallel, an ϳ25% decrease in the UPS activity was observed in denervated EDL muscle after 2 and 3 days of surgery (Fig. 2B) . However, after 4 and 7 days, UPS activity in EDL reverted to control levels. In soleus muscle, the UPS activity was significantly decreased by ϳ20% at the three first experimental intervals (2, 3, and 4 days), but not at 7th day (Fig. 2B) . Because the lysosomal pathway is one of the major protein degradation systems in muscle cells, we investigated the effect of SDEN on lysosomal proteolytic activity. In contrast to UPS, the proteolytic activity of lysosomal pathway in both soleus and EDL muscles was not altered by SDEN in any time studied (Fig. 2C) . These findings suggest that noradrenergic innervation modulates the UPS activity in rat skeletal muscles under control resting conditions.
Effect of sympathetic denervation on cAMP signaling. Because the majority of the intracellular effects of catecholamines in skeletal muscle are mediated by cAMP, we investigated the effects of SDEN on different components of the cAMP/PKA signaling in EDL and soleus muscles of rats. As shown in Fig. 3A , SDEN did not alter the EDL basal active pool of G proteins, determined in the absence of isoproterenol. Also, the total amount of G protein associated to EDL membranes was not affected by denervation (data not shown). The addition of isoproterenol to the incubation medium, at different concentrations, was able to activate G proteins by up to 137% in EDL membranes of both CON and 3-day SDEN rats (Fig. 3A) . However, the cAMP levels was 191% higher in muscles of SDEN compared with those of CON rats (Fig. 3C) , which was consistent with a 112% increase in AC activity induced by SDEN (Fig. 3B) . Furthermore, SDEN increased by 32% the Ser phosphorylation levels of CREB, a well-known target of PKA (Figs. 3, D and E) . Figure 3D also shows that these effects were not associated with phosphorylation of Akt and its downstream target Foxo1, an effect that could prevent Foxo translocation to the nucleus and UPS activation. The 3-day SDEN-induced increase in AC activity and cAMP levels were reverted to basal values 7 days after surgery (Fig. 3, B and C) . In soleus, 3-day SDEN also increased the AC activity (in pmol cAMP/mg protein) in 334% (1,060.2 Ϯ 77.1 vs 244.0 Ϯ 14.7 in CON rats), an effect that was abolished 7 days after surgery (366.9 Ϯ 47.3 vs 341.2 Ϯ 18.7 in CON rats). Taken together, these data suggest that SDEN leads to a transitory adrenergic supersensitivity for cAMP, secondary to the depletion of muscle NE content.
In vitro effect of NE on UPS and cAMP/PKA and Akt/Foxo signaling in isolated muscle. NE, at the concentration of 10 Ϫ4 M, was added to the incubation medium of EDL muscle isolated from normal rats. This concentration was used because our laboratory has previously shown that it causes a statistically significant reduction in the overall proteolysis in EDL muscle (37) . As shown in Fig. 4A , NE reduced the UPS activity by 21%. Additionally, NE reduced basal atrogin-1 (64%) and MuRF1 (43%) mRNA levels (Fig. 4B) . Similar effects were observed in soleus muscle (data not shown). To verify whether the observed effects of NE were mediated via activation of cAMP/PKA signaling pathway, muscle cAMP levels and the phosphorylation levels of CREB were assessed. NE increased muscle cAMP levels by 115% (Fig. 4C ) and the phosphorylation levels of CREB (2.7-fold) in EDL muscle (Fig. 4, D and  E) , indicating increased PKA activity. As Akt/Foxo signaling can be regulated in EDL muscle by EPI in vitro (7), we investigated the phosphorylation levels of Akt and Foxo1 in isolated EDL muscles from normal rats in the presence of NE. Interestingly, NE increased the Ser phosphorylation of Foxo1 (ϳ6-fold), but did not alter the Ser phosphorylation of Akt (Fig. 4, D and E) . Similar results were obtained in serumdeprived C 2 C 12 muscle cells incubated in the presence of FSK (AC activator) (Fig. 5) . Together, our results strength the concept that NE exerts direct antiproteolytic actions in EDL muscle of rats, and these effects are mediated, at least in part, by increasing cAMP levels and inhibiting Foxo1 transcriptional activity and the expression of Ub-ligases.
In vitro effect of 6-BNZ-cAMP on UPS and Akt/Foxo signaling in isolated muscles. To investigate further the role of PKA in the inhibitory effect of NE on UPS, EDL muscles were incubated in the presence of 6-BNZ-cAMP (at the concentration of 500 M), a specific PKA activator. As shown in Fig. 6, A and B, 6-BNZ-cAMP significantly reduced the activity of UPS (45%) and basal MuRF1 mRNA levels (40%), but did not alter the atrogin-1 mRNA. Moreover, 6-BNZ-cAMP increased the Ser phosphorylation levels of CREB (64%) after 30 min, and the Ser phosphorylation levels of Foxo1 (ϳ3-fold) after 120 min of incubation (Fig. 6, C and D) . Interestingly, the Ser phosphorylation levels of Akt were not altered by 6-BNZcAMP at any time interval (Fig. 6, C and D) . Collectively, these data suggest that the suppressive effect of PKA on UPS activity and atrophy-related Ub-ligases expression is mediated by the inhibition of Foxo1 and independently of Akt.
DISCUSSION
The present data show that the SDEN induced by surgical excision at L2 and L3 levels of the sympathetic chain, which innervates rat hindlimb skeletal muscles (6) transiently, decreased rates of total protein degradation in both fast-and slow-twitch skeletal muscles. The lysosomal proteolytic system did not participate in any of the changes observed, as the activity of this system remained unchanged in soleus and EDL throughout the experimental period (Fig. 2C) . The present data also show that the decrease in the rate of overall proteolysis (in both soleus and EDL muscle, during the first 3 days) was accompanied by a parallel decrease in the activity of UPS, occurred without any change in plasma levels of catecholamines (Fig. 1, C and D) , and it was probably a direct consequence of the depletion of muscle NE. This view is consistent with a similar inhibition of the UPS, but not lysosomal activity, that was observed after a short-term adrenergic blockade induced by guanethidine (36), a model of chemical sympathectomy in which both plasma catecholamines and muscle NE are reduced. This antiproteolytic response was interpreted as an adaptive mechanism of the muscle to limit protein breakdown. The present study reinforces this hypothesis and shows, for the first time, that the inhibition of overall protein breakdown and UPS was clearly associated with an increase in the activity of AC and, as consequence, in the levels of cAMP, which in turn induced CREB activation, possibly via PKA (Figs. 2 and 3) . It is interesting to note that the biphasic pattern of proteolysis observed in muscles from denervated rats, with an initial decrease during the first 3 days, followed by a return to the CON values after 7 days (Fig. 2) , has also been observed for cAMP and the activity of AC in both EDL and soleus muscles (Fig. 3, B and C) . Taken together, these data strongly suggest that SDEN induces skeletal muscle adrenergic supersensitivity for cAMP, leading to the suppression of UPS activity under normal conditions, when circulating catecholamines are at normal levels. These data confirm previous investigations demonstrating that chemical and/or surgical sympathectomy induce the development of adaptive supersensitivity in a number of tissues, including cerebral cortex and cardiac muscle (43, 45) . Indeed, the mechanisms underlying sympathectomyinduced adrenergic supersensitivity may include multiple steps of action. The depletion of NE in different tissues leads to an increased number of ␤-adrenergic receptors (45) and/or an alteration in the intracellular transduction processes responsible for the action of an agonist following receptor occupation by that agent (43) . The present finding that the increases in AC activation were not correlated with any detectable change in the levels or activity of G protein (Fig. 3A) suggests that the cellular mechanism that underlies the development of adaptive supersensitivity in the rat skeletal muscle may involve a modification of AC. The subsequent decrease to basal levels in the AC activity observed after 7 days of denervation can be interpreted as a restoration of muscle capacity to limit the cAMP increase (1) and can be advantageous for maintaining the rate of muscle protein degradation. The mechanism of the temporary nature of the increased adrenergic sensitivity in denervated skeletal muscles cannot be explained on the basis of the present data.
Although our in vivo data suggest that the adrenergic supersensitivity induced by SDEN inhibited the UPS activity, it could be argued that this response was a consequence of the lack of NE itself, which would imply that this neurotransmitter acts as a potential activator of UPS system. Alternatively, decreased muscle NE content by lumbar surgical excision could act indirectly by changing insulin responsiveness (24), or regional blood flow. In fact, a significant increase in muscle blood flow following chronic lumbar sympathectomy has been reported in dogs (28) . However, these possibilities seem unlikely, since previous studies from our laboratory have convincingly shown that both catecholamines, EPI and NE, exert a direct inhibitory control of proteolysis in rat skeletal muscle, with the participation of a cAMP-dependent pathway (37, 38) . In agreement, the present data show that NE in vitro increased muscle cAMP levels (Fig. 4C ) and in parallel inhibited the Norepinephrine Effects on Ub-Proteasome System • Silveira WA et al.
activity of UPS (Fig. 4A ) and the gene expression of the atrogin-1 and MuRF1 (Fig. 4B) . These adrenergic effects are probably mediated by ␤ 2 -adrenoceptors, given that clenbuterol, and drugs that induce an increase in the muscle cAMP levels, such as the selective and nonselective cAMP-PDE inhibitors, decreased the basal activity of UPS, levels of Ub-protein conjugates, and expression of atrogin-1 mRNA (20, 21, 30 hyperactivity in 3-mo-old mice lacking both ␣ 2A -and ␣ 2C -adrenergic receptor subtypes (␣ 2A -/␣ 2C ARKO mice) induces hypertrophy in white skeletal muscle, an effect that is associated with suppression of UPS activity (3, 15) . Taken together, these findings suggest that NE released from nerve terminals, through the cAMP signaling, plays a role in suppressing the Ub-proteasome-dependent protein breakdown under normal conditions and implies that the SNS has an antiproteolytic effect in skeletal muscle of rats. Furthermore, catecholamines may act directly on skeletal muscle, not only to decrease proteolysis, but also to increase rates of muscle protein synthesis, especially in situations where the basal rates of protein synthesis are already reduced (35) . Therefore, the reduction of proteolysis and/or stimulation of protein synthesis are adrenergic mechanisms that could explain part of the attenuation of atrophy observed through the application of blood flow restriction, a maneuver that increase plasma levels of NE in human beings without exercise (31) .
Furthermore, we investigated whether or not the in vitro effects of NE on UPS could involve the activation of the canonical cAMP/PKA signaling pathway. It is well-established that the expression of Ub-ligases and the consequent activation of the proteasome are inhibited by the activation of phosphatidylinositol 3-kinase/Akt signaling pathway through the phosphorylation and nuclear exclusion of Foxo transcription factors (41, 44) . Because the production of cAMP on EPI stimulation in isolated muscles may activate Akt/Foxo signaling and inhibit proteolysis (7, 12) , we first postulated that NE would affect this signaling pathway. Interestingly, the data show that NE in vitro increased the Ser phosphorylation levels of CREB and Foxo1, but did not alter the Ser phosphorylation of Akt (Fig. 4, D and E) . Similar effects were obtained in serumdeprived C 2 C 12 muscle cells incubated with FSK (a specific AC activator), suggesting that cAMP and probably PKA mediate the inhibitory actions of NE on Ub-ligases in vitro (Fig.  5) . To further support the notion that NE exerts inhibitory effects on UPS through a PKA-dependent signaling, EDL muscle from normal rats were incubated in the presence of 6-BNZ-cAMP, a specific PKA activator. The present data clearly show that the direct activation of PKA in vitro induced by 6-BNZ-cAMP decreased the UPS activity (Fig. 6A ) and MuRF1 mRNA (Fig. 6B ) and in parallel increased the Ser phosphorylation levels of CREB and Foxo1, without altering Akt phosphorylation (Fig. 6, C and D) . In contrast to the effect of NE in isolated muscle, the 6-BNZ-cAMP did not alter the expression of atrogin-1 mRNA (Fig. 6B) . On the other hand, 6-BNZ-cAMP reduced the mRNA levels of atrogin-1 in C 2 C 12 muscle cells under nutritional stress (data not shown). In agreement with these findings, we have recently found that 6-BNZ-cAMP in vitro significantly suppressed the expression of MuRF1 mRNA in normal and atrophying soleus muscles, but had no effect on atrogin-1 mRNA (21) . The available data do not allow any conclusion about the reason for these differences between MuRF1 and atrogin-1, but the lack of responsiveness of the atrogin-1 mRNA to the 6-BNZ-cAMP could be explained, at least in part, by the fact that the stimulatory effect of the 6-BNZ-cAMP on the phosphorylation levels of Foxo1 and CREB was less potent compared with NE (Figs. 4 and 6 ). To our knowledge, this constitutes the first report that Foxo1 may be a direct substrate for PKA in skeletal muscle cells, a finding that strongly supports similar conclusions in vascular endothelial cells (29) . Further experiments are needed to certify if PKA may directly phosphorylate and inhibit transcriptional activity of Foxo1 under physiological conditions in intact skeletal muscles.
In summary, the present data show that the surgical SDEN induces the phenomenon of adrenergic supersensitivity for cAMP that is associated with suppression of the basal activity of UPS in EDL and soleus muscles. Furthermore, as shown in Fig. 7 , the inhibitory effect of NE on UPS observed in vitro may be mediated through cAMP/PKA activation, leading to the inhibition of Foxo1 transcription factor by phosphorylation and a consequent suppression of atrophy-related Ub-ligases. Based on these data and assuming that the NE released by the sympathetic innervation acts on skeletal muscle through the same mechanisms, the antiproteolytic effects of sympathetic denervation here observed might be an important adaptative effect for preservation of proteins. Finally, these results represent further evidence on the antiproteolytic role of SNS in skeletal muscle and suggest that modulating the cAMP/PKA signaling may serve as a potential target for muscle-wasting conditions in populations characterized by sympathetic dysfunction, such as spinal cord-injured adults.
Norepinephrine Effects on Ub-Proteasome System • Silveira WA et al.
